InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

- Current share price for PME : $176.080

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,395 Interim Dividend Confirmation 24 Feb 2009 5:42PM $0.800 $176.080 risen by 21,910%
$18,395 CEO on H1 Earnings Outlook 24 Feb 2009 4:12PM $0.725 $176.080 risen by 24,186.90%
$18,395 Appendix 4D 24 Feb 2009 3:32PM $0.760 $176.080 risen by 23,068.42%
$18,395 Open Briefing - CEO on Earnings Update 28 Jan 2009 10:22AM $0.830 $176.080 risen by 21,114.46%
$18,395 Open Briefing - CEO on Visage Acquisition 28 Jan 2009 10:22AM $0.830 $176.080 risen by 21,114.46%
$18,395 Market Update 28 Jan 2009 8:32AM $0.860 $176.080 risen by 20,374.42%
$18,395 Acquires US based Visage Imaging Inc 28 Jan 2009 8:29AM $0.860 $176.080 risen by 20,374.42%
$18,395 Open Briefing - Pro Medicus. CEO on FY 09 Outlook 26 Aug 2008 3:58PM n/a $176.080 n/a
$18,395 Appendix 4E - Preliminary Final Report 26 Aug 2008 2:02PM $0.950 $176.080 risen by 18,434.74%
$18,395 Open Briefing Pro Medicus CEO on New Agfa Contract 28 Jul 2008 12:34PM $1.160 $176.080 risen by 15,079.31%
$18,395 Open Briefing CEO and Deputy Chairman on H1 Result 26 Feb 2008 3:30PM $1.160 $176.080 risen by 15,079.31%
$18,395 Half Year Results - Appendix 4D 26 Feb 2008 1:51PM $1.200 $176.080 risen by 14,573.33%
$18,395 Open Briefing Pro Medicus CEO on FY 08 Outlook 28 Aug 2007 5:02PM $1.415 $176.080 risen by 12,343.82%
$18,395 Preliminary Final Report 28 Aug 2007 3:44PM $1.420 $176.080 risen by 12,300%
$18,395 Signs major digital imaging sale 26 Apr 2007 11:07AM $1.370 $176.080 risen by 12,752.55%
$18,395 Half Yearly Report 27 Feb 2007 2:08PM $1.325 $176.080 risen by 13,188.05%
$18,395 Open Briefing Pro Medicus CEO on FY06 Profit Growth 24 Aug 2006 1:04PM $1.375 $176.080 risen by 12,706.75%
$18,395 Preliminary Final Report & Full Year Accounts 24 Aug 2006 11:54AM $1.350 $176.080 risen by 12,942.96%
$18,395 UK & Ireleand deal signals further overseas growth 8 May 2006 11:11AM $1.455 $176.080 risen by 12,005.05%
$18,395 Partial Sell Down Boosts Pro Medicus Stock Liquidity 22 Mar 2006 9:48AM $1.445 $176.080 risen by 12,088.84%
$18,395 Wins $0.6M Digital Imaging Contract 14 Mar 2006 10:23AM $1.699 $176.080 risen by 10,265.57%
$18,395 Open Briefing Pro Medicus CEO on Outlook 27 Feb 2006 2:04PM $1.425 $176.080 risen by 12,259.09%
$18,395 Half Yearly Report & Half Year Accounts 27 Feb 2006 12:37PM $1.495 $176.080 risen by 11,681.87%
$18,395 Pro Medicus Open Briefing: CEO on North American Progress 16 Dec 2005 10:56AM $1.495 $176.080 risen by 11,681.87%
$18,395 Signs Key Sydney Digital Radiology Site 3 Oct 2005 11:21AM $1.275 $176.080 risen by 13,706.95%

626 - 650 of 668 results

Page 26 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.